---
title: Overdose Management - General Principles
type: content
phase: 1
status: complete
priority: high
tags: [toxicology, overdose, decontamination, activated-charcoal, gastric-lavage, enhanced-elimination, hemodialysis, supportive-care]
created: 2025-11-08
last_modified: 2025-11-08
---

# Overdose Management - General Principles

## Introduction

Management of poisoned patients requires a systematic approach prioritizing resuscitation, decontamination (when appropriate), enhanced elimination, specific antidotes, and supportive care. Understanding general principles of overdose management is essential for all healthcare providers.

## Initial Approach - ABCs

### Airway, Breathing, Circulation

**Priority**: **Stabilization before decontamination**

**Airway**:
- **Assess patency**, protect from aspiration
- **Indications for intubation**:
  - GCS <8 (unable to protect airway)
  - Respiratory failure
  - Severe agitation (safety)
  - Anticipated clinical deterioration

**Breathing**:
- **Assess respiratory rate, effort, oxygenation**
- **Supplemental O2** if needed
- **Ventilatory support** if hypoventilation

**Circulation**:
- **Assess perfusion** (BP, HR, capillary refill)
- **IV access**
- **Fluids** for hypotension (20 mL/kg bolus)
- **Vasopressors** if refractory shock

**Disability** (Neurologic):
- **GCS, pupil size**
- **Glucose check** (exclude hypoglycemia)

**Exposure**:
- **Remove contaminated clothing**
- **Decontaminate skin** (if dermal exposure)

---

## History and Physical Examination

### History

**Key Questions** (AMPLE):
- **A**llergies
- **M**edications (prescription, OTC, herbal, illicit)
- **P**ast medical history
- **L**ast meal (timing affects absorption)
- **E**vents (what, when, how much, why)

**Toxidrome Assessment**: See below

**Coingestants**: Multiple substances common

### Physical Examination

**Vital Signs**:
- **Temperature**: Hyperthermia (sympathomimetics, serotonin syndrome) vs. hypothermia (sedatives, opioids)
- **Heart rate**: Tachycardia vs. bradycardia
- **Blood pressure**: Hypertension vs. hypotension
- **Respiratory rate**: Tachypnea (salicylates, metabolic acidosis) vs. bradypnea (opioids, sedatives)

**Focused Exam**:
- **Pupils**: Miosis (opioids, organophosphates) vs. mydriasis (sympathomimetics, anticholinergics)
- **Skin**: Diaphoresis vs. dry, flushed
- **Bowel sounds**: Hyperactive vs. hypoactive
- **Neuromuscular**: Tremor, rigidity, fasciculations, clonus

---

## Toxidromes (Toxic Syndromes)

**Constellation of signs/symptoms** suggesting drug class

### Opioid Toxidrome

**Features**:
- **Miosis** (pinpoint pupils)
- **Respiratory depression** (bradypnea)
- **CNS depression** (sedation, coma)
- **Hypotension**, **bradycardia**

**Causes**: Morphine, heroin, fentanyl, oxycodone, etc.

**Treatment**: **Naloxone** 0.4-2 mg IV

### Sympathomimetic Toxidrome

**Features**:
- **Mydriasis** (dilated pupils)
- **Tachycardia**, **hypertension**
- **Hyperthermia**, **diaphoresis**
- **Agitation**, **seizures**

**Causes**: Cocaine, amphetamines, MDMA, ephedrine

**Treatment**: Benzodiazepines, cooling

### Anticholinergic Toxidrome

**Features** (Mnemonic: "**Hot as a hare, blind as a bat, dry as a bone, red as a beet, mad as a hatter**"):
- **Hyperthermia**
- **Mydriasis** (blurred vision)
- **Dry skin, mucous membranes** (anhidrosis)
- **Flushed** (vasodilation)
- **Delirium**, **hallucinations**
- **Urinary retention**, **↓Bowel sounds**
- **Tachycardia**

**Causes**: Antihistamines, TCAs, atropine, jimsonweed, diphenhydramine

**Treatment**: Supportive (benzodiazepines for agitation), physostigmine (rarely)

### Cholinergic Toxidrome

**Features** (Mnemonic: "**SLUDGE**"):
- **S**alivation, **L**acrimation, **U**rination, **D**efecation, **G**I upset, **E**mesis
- **Miosis**
- **Bronchospasm**, **bronchorrhea**
- **Bradycardia**
- **Muscle fasciculations** (nicotinic)

**Causes**: Organophosphates, carbamates, physostigmine, pilocarpine

**Treatment**: **Atropine** + **pralidoxime** (organophosphates)

### Sedative-Hypnotic Toxidrome

**Features**:
- **CNS depression** (sedation, coma)
- **Respiratory depression**
- **Hypotension**, **bradycardia**
- **Hypothermia**

**Causes**: Benzodiazepines, barbiturates, ethanol, GHB

**Treatment**: Supportive, flumazenil (benzodiazepines - rarely)

### Serotonin Syndrome

**Features** (Triad):
- **Mental status changes** (agitation, confusion)
- **Autonomic hyperactivity** (tachycardia, hyperthermia, diaphoresis, mydriasis)
- **Neuromuscular abnormalities** (clonus, hyperreflexia, rigidity, tremor)

**Causes**: SSRIs, SNRIs, MAOIs, tramadol, linezolid (especially combinations)

**Treatment**: Stop drug, benzodiazepines, cooling, cyproheptadine

---

## Decontamination

**Goal**: ↓Absorption of toxin

**General Principle**: **Benefit must outweigh risk**

### Gastrointestinal Decontamination

#### Activated Charcoal

**Mechanism**: **Adsorbs drugs** in GI tract → prevents absorption

**Indications**:
- **Within 1 hour** of ingestion (optimal)
- **May consider up to 2-4 hours** (delayed gastric emptying)
- **Potentially life-threatening ingestion**

**Dose**:
- **Adults**: 50-100 g PO/NG
- **Children**: 1 g/kg (max 50 g)

**Efficacy**: ↓Absorption 50-90% (if given within 1 hour)

**Contraindications**:
- **Unprotected airway** (aspiration risk)
- **GI perforation, obstruction**
- **Substance not adsorbed** (see below)

**Substances NOT Adsorbed** (Mnemonic: "**PHAILS**"):
- **P**etroleum distillates
- **H**eavy metals (iron, lead, lithium)
- **A**lcohols (ethanol, methanol, ethylene glycol)
- **I**odine, **I**ron
- **L**ithium
- **S**olvents

**Adverse Effects**:
- **Aspiration** (pneumonitis - most serious)
- Constipation, black stools (benign)
- Vomiting

**Multiple-Dose Activated Charcoal (MDAC)**:
- **Mechanism**: ↑Elimination (interrupts enterohepatic/enteroenteric circulation)
- **Indications**:
  - **Life-threatening ingestion** of drugs with enterohepatic circulation
  - **Carbamazepine, phenobarbital, theophylline, dapsone, quinine**
- **Dose**: 25-50 g q4-6h
- **Contraindications**: Same as single-dose, plus ↑obstruction risk

**Clinical Pearl**: **Give early (<1 hour)**, **protect airway first**

#### Gastric Lavage

**Mechanism**: Physical removal of gastric contents

**Indications** (Rarely Used):
- **Life-threatening ingestion** within 1 hour
- **Unable to give activated charcoal**

**Technique**:
- **Large-bore orogastric tube** (36-40 French)
- **Protect airway** (intubate if needed)
- **Lavage with saline** (200-300 mL aliquots) until clear

**Contraindications**:
- **Corrosives** (risk perforation)
- **Hydrocarbons** (aspiration risk)
- **Unprotected airway**
- **Significant time elapsed** (>1 hour)

**Adverse Effects**:
- Aspiration, esophageal/gastric perforation, laryngospasm

**Clinical Pearl**: **Largely abandoned** (limited benefit, significant risks)

#### Whole Bowel Irrigation (WBI)

**Mechanism**: **Flushes GI tract** with polyethylene glycol solution

**Indications** (Specific):
- **Sustained-release preparations**
- **Iron**
- **Body packers** (drug smuggling)
- **Substances not adsorbed by charcoal** (lithium)

**Technique**:
- **Polyethylene glycol-electrolyte solution** (GoLYTELY)
- **2 L/h** (adults) via NG tube until rectal effluent clear

**Contraindications**:
- **Ileus, obstruction, perforation**
- **Unprotected airway**
- **Hemodynamic instability**

**Clinical Pearl**: **Consider for iron, sustained-release, body packers**

#### Syrup of Ipecac

**Status**: **No longer recommended** (AACT, AAP guidelines)
- Limited efficacy, delays charcoal, aspiration risk

### Dermal Decontamination

**Indications**:
- **Dermal exposure** (pesticides, caustics, toxic plants)

**Technique**:
- **Remove clothing** (double-bag)
- **Wash with soap and water** (copious)
- **Protect providers** (gloves, gowns)

**Duration**: 15-20 minutes (longer for caustics)

### Ocular Decontamination

**Indications**: Eye exposure (chemicals, caustics)

**Technique**:
- **Irrigate with saline or water** (20-30 minutes minimum)
- **Remove contact lenses**
- **Check pH** (goal: 7-7.5)
- **Continue until neutral pH**

**Clinical Pearl**: **Immediate irrigation** (before transport if possible)

---

## Enhanced Elimination

**Goal**: ↑Drug removal from body

### Urinary Alkalinization

**Mechanism**: **↑Urinary pH** → **ion trapping** → ↑renal excretion (weak acids)

**Indications**:
- **Salicylates** (aspirin)
- **Chlorophenoxy herbicides**
- **Methotrexate** (high-dose toxicity)

**Technique**:
- **Sodium bicarbonate**: 150 mEq (3 amps) in 1 L D5W
- **Infuse at 2-3× maintenance rate**
- **Goal urine pH**: 7.5-8.5

**Monitoring**:
- **Urine pH** (q2-4h)
- **Serum K+** (replete K+ - hypokalemia prevents alkalinization)
- **Serum pH** (avoid systemic alkalosis >7.55)

**Contraindications**: Volume overload, pulmonary/cerebral edema

**Clinical Pearl**: **Essential for salicylate toxicity** (↑renal clearance)

### Hemodialysis

**Mechanism**: **Removes drug** via semipermeable membrane

**Indications** (Substance Properties):
- **Small molecular weight** (<500 Da)
- **Water-soluble** (low Vd)
- **Low protein binding**
- **Renal clearance normally**

**Specific Indications** (Mnemonic: "**SLIME**"):
- **S**alicylates
- **L**ithium
- **I**soniazid
- **M**ethanol
- **E**thylene glycol

**Other**: Theophylline, valproic acid, metformin (lactic acidosis)

**Also Consider**:
- **Severe poisoning** (life-threatening)
- **Renal failure** (↓elimination)
- **Acid-base disturbance**

**Technique**: Continuous (CRRT) or intermittent (IHD)

**Clinical Pearl**: **Dialyze toxic alcohols** (methanol, ethylene glycol) + fomepizole

### Hemoperfusion

**Mechanism**: Blood passes through **activated charcoal cartridge**

**Advantages**: Removes **protein-bound, lipophilic** drugs (better than hemodialysis)

**Indications** (Rarely Used):
- **Theophylline** (severe)
- Carbamazepine, phenobarbital (severe, not responding)

**Disadvantages**:
- **Thrombocytopenia**, leukopenia
- Less available than hemodialysis

**Status**: **Largely replaced by CRRT** (continuous renal replacement therapy)

---

## Specific Overdoses - Key Points

### Acetaminophen

**Mechanism**: NAPQI (toxic metabolite) → GSH depletion → hepatotoxicity

**Stages**:
1. **<24h**: Nausea, vomiting, anorexia
2. **24-72h**: RUQ pain, ↑AST/ALT
3. **72-96h**: Peak hepatotoxicity (↑AST/ALT, ↑INR, encephalopathy)
4. **4-14 days**: Recovery or fulminant hepatic failure

**Diagnosis**:
- **Acetaminophen level** 4 hours post-ingestion
- **Rumack-Matthew nomogram** (plot level vs. time)

**Treatment**:
- **N-acetylcysteine** (NAC) - see Antidotes section
- **Most effective <8 hours**, but beneficial up to 24-48h

**Criteria for Transplant**:
- King's College Criteria (pH <7.3, INR >6.5, Cr >3.4, encephalopathy)

### Salicylates (Aspirin)

**Mechanism**: Uncouples oxidative phosphorylation, stimulates respiratory center

**Clinical Features**:
- **Tinnitus** (early)
- **Respiratory alkalosis** (hyperventilation - direct CNS stimulation)
- **Metabolic acidosis** (later - uncoupling)
- **Hyperthermia**, **diaphoresis**
- **CNS toxicity** (confusion, seizures, coma)
- **Pulmonary edema** (non-cardiogenic)

**Diagnosis**:
- **Salicylate level**:
  - **Acute**: >30 mg/dL toxic, >100 mg/dL severe
  - **Chronic**: Lower levels toxic (tissue accumulation)
- **ABG**: Mixed respiratory alkalosis + metabolic acidosis

**Treatment**:
1. **Activated charcoal** (if early, repeat doses)
2. **Urinary alkalinization** (sodium bicarbonate):
   - **Goal urine pH 7.5-8.5**
   - ↑Renal excretion 10-20×
3. **Hemodialysis** (if severe):
   - Indications: Level >100 mg/dL, refractory acidosis, altered mental status, pulmonary edema, renal failure
4. **Supportive**: Fluids, glucose, K+ repletion

**Clinical Pearl**: **Do NOT hyperventilate** (↓respiratory compensation worsens acidosis)

### Tricyclic Antidepressants (TCAs)

**Mechanism**: Na+ channel blockade (cardiac), anticholinergic, α-blockade

**Clinical Features**:
- **Anticholinergic** toxidrome (see above)
- **Cardiac**: **QRS widening** (>100 ms), **ventricular arrhythmias**, hypotension
- **Seizures**
- **CNS depression** → coma

**Diagnosis**:
- **ECG**: **QRS >100 ms** predicts toxicity, **R wave in aVR >3 mm**

**Treatment**:
1. **Sodium bicarbonate**:
   - **For QRS widening or arrhythmias**
   - **Bolus: 1-2 mEq/kg IV** (50-100 mEq)
   - **Infusion**: 150 mEq in 1 L D5W
   - **Mechanism**: ↑Serum Na+ → overcomes Na+ channel blockade, alkalinization
   - **Goal pH**: 7.50-7.55
2. **Activated charcoal** (if early)
3. **Benzodiazepines** (seizures)
4. **Avoid**:
   - **Class IA, IC antiarrhythmics** (worsen Na+ blockade)
   - **Physostigmine** (may cause asystole)

**Clinical Pearl**: **Sodium bicarbonate** for QRS >100 ms or arrhythmias

### Digoxin

**Clinical Features**:
- **GI**: Nausea, vomiting, anorexia
- **Cardiac**: Bradycardia, heart block, **bidirectional VT**
- **Vision**: Yellow-green halos
- **Hyperkalemia** (inhibits Na+/K+-ATPase)

**Treatment**:
- **Digoxin-specific antibodies** (Digibind, DigiFab) - see Antidotes
- Indications: Life-threatening arrhythmias, K+ >5.5, level >10-15 ng/mL

### Beta-Blockers and Calcium Channel Blockers

**Clinical Features**:
- **Bradycardia**, **hypotension**
- **Heart block** (AV conduction delay)
- **Hyperglycemia** (β-blockers) vs. hypoglycemia (CCBs)

**Treatment**:
1. **IV fluids**
2. **Atropine** (bradycardia)
3. **Glucagon** (β-blockers):
   - **5-10 mg IV** bolus, then 1-10 mg/h infusion
   - Bypasses β-receptor
4. **Calcium** (CCBs):
   - **Calcium chloride 10%**: 10-20 mL IV (or calcium gluconate 30-60 mL)
   - Repeat as needed
5. **High-dose insulin + glucose** (euglycemic therapy):
   - **Insulin**: 1 unit/kg bolus, then 0.5-1 unit/kg/h
   - **Dextrose**: Maintain euglycemia (D10W or D50W)
   - **Mechanism**: ↑Inotropy, ↑vascular tone
   - **Monitor K+** (may ↓)
6. **Vasopressors** (norepinephrine, epinephrine)
7. **Lipid emulsion** (refractory cases - see below)

### Lipid Emulsion Therapy

**Mechanism** (Controversial):
- **"Lipid sink"**: Sequesters lipophilic drugs
- **↑Cardiac energy substrate**

**Indications**:
- **Refractory cardiovascular collapse** from lipophilic drugs:
  - **Local anesthetics** (bupivacaine, ropivacaine) - FDA-approved
  - **Beta-blockers, CCBs, TCAs** (case reports)

**Dose**:
- **20% lipid emulsion** (Intralipid)
- **Bolus**: 1.5 mL/kg over 1 minute
- **Infusion**: 0.25 mL/kg/min
- **Repeat bolus** q5min PRN (max 3 mL/kg total bolus)

**Adverse Effects**: Pancreatitis, fat embolism, lab interference

**Clinical Pearl**: **Consider for refractory local anesthetic toxicity**

---

## Supportive Care

**Foundation** of toxicology management

**Airway**: Intubate if GCS <8 or unable to protect

**Seizures**: **Benzodiazepines** (lorazepam 2-4 mg IV, diazepam 5-10 mg IV)

**Hypotension**:
- **IV fluids** (first-line): 20 mL/kg bolus
- **Vasopressors** if refractory (norepinephrine)

**Hypertension**:
- **Benzodiazepines** (sympathomimetics)
- **Antihypertensives** if severe/refractory

**Hyperthermia**:
- **External cooling** (ice packs, cooling blankets)
- **Benzodiazepines** (↓muscle activity)
- **Consider neuromuscular blockade** (severe - requires intubation)

**Agitation**:
- **Benzodiazepines** (lorazepam, midazolam)
- **Physical restraints** (if necessary for safety)

**Monitoring**:
- **Continuous cardiac monitoring**, pulse oximetry
- **Frequent vital signs**
- **Labs**: Electrolytes, glucose, renal function, specific drug levels

---

## Clinical Pearls

1. **ABC first** (stabilize before decontamination)
2. **Activated charcoal** (<1 hour, protect airway)
3. **Gastric lavage rarely indicated** (risks > benefits usually)
4. **Urinary alkalinization** for salicylates (↑renal excretion)
5. **Hemodialysis** for SLIME (salicylates, lithium, isoniazid, methanol, ethylene glycol)
6. **Sodium bicarbonate** for TCA-induced QRS widening
7. **Supportive care** cornerstone (few antidotes)
8. **Benzodiazepines** for sympathomimetic agitation, seizures
9. **Toxidromes** help identify drug class
10. **Consult poison control** (1-800-222-1222)

---

## Key Takeaways

1. **Initial stabilization**: ABCs, IV access, glucose check
2. **Decontamination**: Activated charcoal (<1 hour), protect airway, limited role for lavage
3. **Enhanced elimination**: Urinary alkalinization (salicylates), hemodialysis (SLIME)
4. **Toxidromes**: Opioid, sympathomimetic, anticholinergic, cholinergic, sedative
5. **Acetaminophen**: NAC most effective <8h, use Rumack-Matthew nomogram
6. **Salicylates**: Urinary alkalinization, hemodialysis if severe, don't hyperventilate
7. **TCAs**: Sodium bicarbonate for QRS >100 ms, benzodiazepines for seizures
8. **β-blockers/CCBs**: Glucagon (β), calcium (CCB), high-dose insulin, lipid emulsion
9. **Supportive care**: Benzodiazepines (seizures, agitation), fluids (hypotension), cooling (hyperthermia)
10. **Poison control**: 1-800-222-1222 (expert consultation)

---

## References

1. Katzung's Basic & Clinical Pharmacology, 15th Edition
2. Goldfrank's Toxicologic Emergencies, 11th Edition
3. American Academy of Clinical Toxicology Practice Guidelines
4. Poisindex® Toxicologic Managements (Micromedex)
5. Dart RC. Medical Toxicology, 3rd Edition
